导师姓名： 董柏君 专业代码： 100210
性别： 男 专业名称： 外科学
培养单位： 附属仁济医院 三级学科/
专业领域： 泌尿外
导师类型： 硕士生导师 专业学位导师：
联系方式： E-Mail: dongbaijun@renji.com
邮编： 200127 邮箱地址： dongbaijun@renji.com

研究方向 (点击浏览详细信息)
前列腺癌

社会任职
上海市泌尿外科学会青年委员会副主任委员
中国抗癌协会肿瘤介入学专业委员会消融专家委员会委员
国际冷冻学会委员
中国医师协会泌尿外科分会青年委员
中华医学会泌尿外科分会青年委员

科研项目 项目编号项目名称课题来源起止年月批准经费承担职责
YG2017MS47 3D打印指导下的前列腺靶向冷冻消融 上海交通大学医工交叉面上项目 2018-01~2020-12 21万元 课题负责人
外周血游离DNA检测在转移性去势抵抗性前列腺癌靶向治疗预测预后中的应用 上海市卫计委 2017-01~2019-12 5万元 课题负责人
** HOXD13在去势抵抗性前列腺癌转移和神经内分泌分化中的作用 国家自然基金面上项目 2017-01~2020-12 58万元 课题负责人
15ZZ058 端粒失保护在前列腺癌进展转移中的作用和分子机制 上海市教委 2015-01~2017-12 8万元 课题负责人

学术论文 作者论文标题期刊名出版年卷期页码
Fan L#, Wang R#, Chi C#, Cai W, Zhang Y, Qian H, Shao X, Wang Y, Xu F, Pan J, Zhu Y, Shangguan X, Zhou L, Dong B* （通讯作者）, Xue W*. Systemic immune- inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients. Prostate 2018 78(4):250-256.
Xin Z#, Zhang Y#, Jiang Z, Zhao L, Fan L, Wang Y, Xie S, Shangguan X, Zhu Y, Pan J, Liu Q, Huang Y, Dong B* （通讯作者）, Xue W*. Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate. Hum Pathol. 2018 S0046-8177(18)30182-5
Zheng H#, Cai A, Zhou Q, Xu P, Zhao L, Li C, Dong B* （通讯作者）, Gao H*. Optimal preprocessing of serum and urine metabolomic data fusion for staging prostate cancer through design of experiment. Anal Chim Acta. 2017 991:68-75.
Fan L#, Chi C#, Guo S#, Wang Y, Cai W, Shao X, Xu F, Pan J, Zhu Y, Shangguan X, Xin Z, Hu J, Qian H, Xie S, Wang R, Zhou L, Dong B* （通讯作者）, Xue W*. Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone J Cancer. 2017 8(17):3448-3455.
Dong B#, Fan L#, Wang Y#, Chi C, Ma X, Wang R, Cai W, Shao X, Pan J, Zhu Y, Shangguan X, Xin Z, Hu J, Xie S, Kang X, Zhou L*, Xue W*. Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy-naive metastatic castration-resistant prostate cancer. Prostate 2017 77(13): 1373-1380.
Wang YQ#, Zhu YJ#, Pan JH, Xu F, Shao XG, Sha JJ, Liu Q, Huang YR, Dong BJ* （通讯作者）, Xue W*. Peripheral monocyte count: an independent diagnostic and prognostic biomarker for prostate cancer - a large Chinese cohort study. Asian J Androl. 2017 19(5):579-585.
Fan L#, Wang Y#, Chi C#, Pan J, Shangguan X, Xin Z, Hu J, Zhou L, Dong B* （通讯作者）, Xue W*. Chromogranin A and neurone-specific enolase variations during the first three months of abiraterone therapy predict outcomes in patients with metastatic castration-resistant prostate cancer. BJU Int. 2017 120(2):226-232.
Wang Y#, Xie S#, Shangguan X, Pan J, Zhu Y, Xin Z, Xu F, Shao X, Fan L, Sha J, Liu Q, Dong B* （通讯作者）, Xue W*. Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population. J Cancer Res Clin Oncol. 2017 143(7):1157-1166.
Wang Y#, Chen W#, Hu C#, Wen X#, Pan J, Xu F, Zhu Y, Shao X, Shangguan X, Fan L, Sha J, Wang Z, Cai Y, Liu Q, Dong B* （通讯作者）, Xue W*. Albumin and Fibrinogen Combined Prognostic Grade Predicts Prognosis of Patients with Prostate Cancer. J Cancer. 2017 8(19):3992-4001.
Dong B#, Gao Y#, Kang X#, Gao H#, Zhang J, Guo H, You MJ, Xue W, Cheng J*, Huang Y*. SENP1 promotes proliferation of clear cell renal cell carcinoma through activation of glycolysis. Oncotarget. 2016 7(49):80435-80449.
Xu F#, Gao Y#, Wang Y#, Pan J#, Sha J, Shao X, Kang X, Qin J, James You M, Huang Y, Dong B* （通讯作者）, Xue W*. Decreased TSPAN1 promotes prostate cancer progression and is a marker for early biochemical recurrence after radical prostatectomy. Oncotarget. 2016 7(39):63294-63305.